Chemosense Therapeutics

Shrinking dosage / Shrinking side effects / Shrinking tumors

The Problem


Cause of death (cancer)


Estimated cancer deaths in the US in 2020


Success rate of new first-in-human oncology drugs

The Solution

Repurposing existing drugs as novel cancer therapeutic

Drug repurposing or repositioning is a strategy of finding new indications for already known marketed drugs used in various clinical settings. This can give new life to drugs currently used in the clinic, or shelved drugs that failed initial tests for their main indication. This strategy has immense promise over the existing strategy of developing novel first-in-human compounds.

Cost Effective

Costs approximately 8x less to repurpose a drug for a new indication than to develop a novel drug.

Quick Translation

Previous clinical trial data and years of use in humans allows repurposed drugs to move more quickly to market.

Higher Success Rate

In recent years, 30% of newly FDA approved drugs were repurposed drugs.

“Chemosense’s mission is to promote the survival and wellbeing of people suffering from cancer through the development of powerful new therapies.”


Meet the Chemosense Team

June 19, 2020

Small Business Health IT & Life Sciences grant

Chemosense is awarded a GSI and Commerce Small Business Health IT & Life Sciences grant.
June 19, 2020

2020 American Society of Clinical Oncology (ASCO)

Chemosense makes a virtual appearance at the 2020 American Society of Clinical Oncology (ASCO) Meeting by presenting an abstract on the ability of our novel therapeutics to resensitize chemoresistant lung…
June 19, 2020

Early Investigator Research Award

Dr. Bland is awarded an Early Investigator Research Award from the Department of Defense Congressionally Directed Medical Research Programs to support his research into muscarinic signaling in chemoresistant prostate cancer.

Connect with Us